Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

May 09, 2024

BUY
$2.87 - $3.94 $80,483 - $110,489
28,043 New
28,043 $88,000
Q2 2023

Apr 29, 2024

BUY
$2.21 - $4.52 $61,975 - $126,754
28,043 New
28,043 $108,000
Q2 2023

Aug 10, 2023

BUY
$2.21 - $4.52 $61,975 - $126,754
28,043 New
28,043 $108,000

Others Institutions Holding NAUT

About Nautilus Biotechnology, Inc.


  • Ticker NAUT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,663,000
  • Market Cap $284M
  • Description
  • Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...
More about NAUT
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.